Charles River Laboratories
262 hedge funds and large institutions have $2.6B invested in Charles River Laboratories in 2014 Q2 according to their latest regulatory filings, with 41 funds opening new positions, 97 increasing their positions, 91 reducing their positions, and 34 closing their positions.
30% more call options, than puts
Call options by funds: $4.11M | Put options by funds: $3.16M
21% more first-time investments, than exits
New positions opened: 41 | Existing positions closed: 34
2% more funds holding
Funds holding: 258 → 262 (+4)
7% more repeat investments, than reductions
Existing positions increased: 97 | Existing positions reduced: 91
0.32% less ownership
Funds ownership: 100.86% → 100.54% (-0.32%)
10% less capital invested
Capital invested by funds: $2.9B → $2.6B (-$297M)
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
+$79.4M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$47.3M |
| 3 |
Norges Bank
Oslo,
Norway
|
+$26.8M |
| 4 |
CAM
Cortina Asset Management
Milwaukee,
Wisconsin
|
+$19M |
| 5 |
RFC
Russell Frank Company
Seattle,
Washington
|
+$17.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FAM
Fred Alger Management
New York
|
-$55.5M |
| 2 |
Millennium Management
New York
|
-$39.4M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
-$37.1M |
| 4 |
EVM
Eaton Vance Management
Boston,
Massachusetts
|
-$29.4M |
| 5 |
Renaissance Technologies
New York
|
-$25.7M |
CRL Hedge Fund Activity: Q2 2014 in Review
262 of the 3,491 institutional investors tracked by Wall St. Rank reported a position in Charles River Laboratories (CRL) for Q2 2014, worth a combined $2.6B — down 10% from $2.9B a quarter earlier.
Buyers outnumbered sellers: 41 funds opened new CRL positions and 34 closed out — a net gain of 7 holders — while 97 added to existing stakes and 91 trimmed.
The largest buyer was Acadian Asset Management, adding an estimated $79.4M. The largest seller was Fred Alger Management, exiting entirely with an estimated $55.5M sold.
- 262 institutional investors held Charles River Laboratories (CRL) as of Q2 2014, up from 258 in Q1 2014.
- Funds reported $2.6B of Charles River Laboratories stock for Q2 2014, down 10% quarter-over-quarter.
- 41 funds opened new Charles River Laboratories positions in Q2 2014 and 34 closed out, a net change of +7 holders.
- The largest Charles River Laboratories buyer in Q2 2014 was Acadian Asset Management, an estimated $79.4M added.
- The largest Charles River Laboratories seller in Q2 2014 was Fred Alger Management, an estimated $55.5M sold.
Based on aggregated 13F filings for Q2 2014.